We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Forum Malta fl-Ewropa has organised the first consultation meetings with civil society on draft EU laws, one concerning the proposed directive on medical devices and the other on proposed regulation regarding the Community patent.
Have you recently had 5 or 6 French gauge diagnostic cardiac catheterization procedures, but are plagued by those pesky puncture site femoral artery leaks? Well have no fear, the StarClose Vascular Closure System (VCS) from Abbot Vascular Devices has been approved to market by the FDA.
Guidant Corporation today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in high surgical risk patients, called CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events).
Omni-Tract Surgical has launched the Omni-Flex retractor System, a table-mounted surgical retractor system providing optimal exposure in a variety of surgical procedures.
Following a planned interim review, an independent data safety monitoring board (DSMB) has recommended the continuation of the Phase III clinical trial of Medidur, Alimera Sciences, an ophthalmic pharmaceutical company, and pSivida, a bionanotech company, have announced.
Hoffman Laboratories' wearable CPAP (Continuous Positive Airway Pressure) device for the treatment of sleep apnea will be introduced at the Medtrade Spring convention in Las Vegas, the company has reported.
St. Jude Medical, Inc. today announced U. S. Food and Drug Administration (FDA) approval and launch of its next generation vascular closure device, the Angio-Seal VIP.
While Abbott Laboratories is nearing completion of an acquisition that will make the company a first-tier player in the business of unclogging arteries to the heart, the North Chicago drug and medical products giant this week made progress on its own stent.
Faced with a persistent questioner who asked him what could
be done to help her elderly mother understand Medicare's new prescription drug plan, President Bush offered a suggestion that at first elicited shocked gasps, and then supportive applause, from an audience of retirees in Silver Spring yesterday.